Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.33.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Avenue Capital Marc Lasry | 62,887 | $238,971 | 0.23% | |
2. | Renaissance Technologies Jim Simons | 21,700 | $82,460 | -70% | 0% |
3. | Marshall Wace LLP Paul Marshall And Ian Wace | 21,247 | $80,739 | 0% | |
4. | Citadel Investment Group Ken Griffin | 14,765 | $56,107 | +48% | 0% |
5. | 3,100 | $11,780 | -79% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.01 | 5,265,165 | Large Shareholder | 12,131,554 | 2023-11-24 | Filing | |
$2.27 | 10,000 | 484,455 | 2023-12-06 | Filing | ||
$2.57 | 5,000 | 474,455 | 2023-12-04 | Filing | ||
$2.05 | 20,000 | 469,455 | 2023-11-29 | Filing | ||
$2.03 | 50,500 | 50,500 | 2023-11-17 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.01 | 5,265,165 | Large Shareholder | 8,400 | 2023-11-24 | Filing | |
$11.62 | 9,210 | Director | 66,445 | 2022-08-17 | Filing | |
$10.51 | 71,042 | Director | 75,655 | 2022-08-17 | Filing | |
$11.62 | 9,210 | Director | 65,124 | 2022-08-17 | Filing | |
$10.51 | 71,042 | Director | 74,334 | 2022-08-17 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 668,347 | $2,218,912 | 0% | |
2. | 493,584 | $1,638,699 | 1.02% | |
3. | 481,300 | $1,597,916 | 0.03% | |
4. | 448,492 | $1,488,993 | 0.06% | |
5. | 114,259 | $379,340 | 0% |